folfirinox Clinical Research Trials | TrialX

Loading...

Please select a valid location from the dropdown

Filter By

Clear all Advanced

Advanced Filters

Gender
Phase
Study Type
Sponsors
Accepts healthy volunteers
Online Trials
Age Group

Any (1)

Phase 2/3 (1)

Interventional (1)

Blokhin's Russian Cancer Research Center (1)

No (1)

No (1)

Adult (18+) (1)

I am/have/had

I am/have/hadimmunodeficiency

I am/have/hadadenocarcinoma of the gastroesophageal junction

I am/have/hadabsolute neutrophil count

I am/have/hadneutrophil count

I am/have/hadadenocarcinoma

I am/have/hadhepatitis b

I am/have/hadHIV Infection

I am/have/hadflot regimen

I am/have/hadhepatitis

I am/have/hadgastric tumor

I am/have/hadgastrointestinal neoplasms

I am/have/hadstomach neoplasm

I am/have/hadgastric adenocarcinoma

I am/have/hadflot

I am/have/hadcytostatic chemotherapy

I am/have/hadcombination chemotherapy

I am/have/hadmetastasis

added new label for I am/have/had

more

I am looking for

I am looking forhepatitis b

I am looking forcombinations

I am looking forleucovorin

I am looking foririnotecan

I am looking forcytostatic

I am looking foroxaliplatin

I am looking forfolfirinox

I am looking fordocetaxel

I am looking forfluorouracil

added new label for I am looking for

more

Advanced Filters

Loading...

Found 1 clinical trials

We call this “infoimagery”. It is unique to every trial and is generated based on a trials specific data eg. therapeutic area, study type, phase etc. and the centerwatch system associates the information to a matching set of related symbols and icons.

What's this?

Phase 2
For Seniors
For adults
Recruiting in 100s
Interventional Study
all
Family Medicine
Recruiting

FOLFIRINOX vs FLOT Chemotherapy for Resectable Gastric or Esophagogastric Junction Adenocarcinoma

One half of the patients gets 5-Fluorouracil (5-FU), Leucovorin, Oxaliplatin and Docetaxel (FLOT), the others 5-Fluorouracil (5-FU), Leucovorin, Oxaliplatin and Irinotecan (FOLFIRINOX). Main objective of the study is median overall survival.

combinations

immunodeficiency

oxaliplatin

adenocarcinoma of the gastroesophageal junction

absolute neutrophil count

0 views
19 Feb, 2024

Congrats! You have your own personal workspace now.

Learn more

© Copyright TrialX 2025 All rights reserved.